A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States (TRUMPET)
The TRUMPET registry is looking at how advanced prostate cancer is treated across the US. It is also exploring how treatments for prostate cancer can affect daily life.
Information will be collected at routine medical visits, and caregivers are also able to take part if they wish. Information from the TRUMPET Registry could help doctors learn how to better treat men living with prostate cancer in the future.
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
- are 18 years of age or older
- have prostate cancer that has progressed (i.e. it has grown or spread) despite initial hormonal or surgical treatments
- are starting, or have recently started, a new treatment for prostate cancer.
Additional information:
If you decide to take part in the TRUMPET Registry, you will continue to receive your usual care and treatment from your regular doctor. There are no extra visits, medication, tests, or examinations as part of the registry. You will need to complete questionnaires about your health once every 3 months (you will receive a gift card as compensation for your time spent completing these).
Primary disease category: Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Projected enrollment dates: November 2016 to April 2021
Official study title: A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States (TRUMPET)
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT02380274